Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

.... Does anyone see this as a problem?? Leronlima

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 153815
(Total Views: 726)
Posted On: 04/11/2020 3:09:28 PM
Posted By: dejavu
Re: COInvestor #26899
.... Does anyone see this as a problem?? Leronlimab is curing patients that Remdesivir did NOTHING for... Gilead was giving China Remdesivir for free for months, and nada! Now "68% of patients improving"??

How many patients are going to get Leronlimab after Remdesivir fails, and improve Gilead's results for them?

https://www.bloomberg.com/news/articles/2020-...remdesivir
Quote:

UCLA Dr. Otto Yang Leading both Cytodyn & Gilead Clinical Trials vs. Covid-19!

I too was so moved by the story of the Seal Beach patient who recovered from Covid-19, I had to see what more was to this story... and found this connection that Dr. Yang is leading both Gilead's Clinical Trial and the CBS story says he is now also leading Cytodyn's Leronlimab.

How incredible is this for Covid-19 patients, the Drs. are building their arsenal of weapons against this horrible virus and they are starting to show that the the really "Big Gun" is Pro 140!

https://www.uclahealth.org/ucla-clinical-tria...t-covid-19

Dr. Otto Yang, professor of medicine, division of infectious diseases, at the David Geffen School of Medicine at UCLA, is leading this trial, with substantial support from the UCLA Clinical and Translational Science Institute.

Read More: https://investorshangout.com/post/newpost/605...z6JKg3thIr



(0)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us